Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273689 · ClinicalTrials.gov registry record · Phase 4
Exercise Induced Bronchospasm in Children
A Phase 4 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00273689 is a Phase 4 study that has completed, run by University of New Mexico. The registered enrollment target is 13 participants.
The verdict
NCT00273689, a Phase 4 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.
Interventions
- DRUG montelukast
- DRUG montelukast vs pretreatment with albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00273689
The ClinicalTrials.gov registry entry for NCT00273689 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which montelukast is the first listed.
NCT00273689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00273689 about?
NCT00273689 is a clinical study titled "Exercise Induced Bronchospasm in Children". The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine...
What is the current status of trial NCT00273689?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2005-12. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00273689?
The interventions under investigation include: montelukast (DRUG), montelukast vs pretreatment with albuterol (DRUG).
Who is sponsoring clinical trial NCT00273689?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.